aminoimidazole carboxamide has been researched along with everolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, Y; Guo, SY; Huo, HZ; Liu, WY; Qin, J; Wang, B | 1 |
1 other study(ies) available for aminoimidazole carboxamide and everolimus
Article | Year |
---|---|
AMP-activated protein kinase (AMPK)/Ulk1-dependent autophagic pathway contributes to C6 ceramide-induced cytotoxic effects in cultured colorectal cancer HT-29 cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein-1 Homolog; Cell Survival; Ceramides; Colorectal Neoplasms; Enzyme Activation; Everolimus; HCT116 Cells; HT29 Cells; Humans; Intracellular Signaling Peptides and Proteins; Protein Serine-Threonine Kinases; Ribonucleotides; Signal Transduction; Sirolimus | 2013 |